New research explores association between hyperurecimia and gout with metabolic derangement
Search results for: anakinra
Treatment, Management Options for Difficult-to-Control Gout
Patient education is key to medication compliance, battling gouty flares
Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat
Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease
Metabolic Syndrome Linked to Higher Risk for Immunological Disorders
Research suggests patients with metabolic disorders, such as diabetes, might benefit from antiinflammatory drugs used to treat immunlogical disorders
Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium
Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care
ACR Issues sJIA Recommendations, SSc Classification Criteria
Guidelines address advances in pathophysiology and treatment of systemic juvenile idiopathic arthritis; criteria classify broader spectrum of systemic sclerosis
New Insights into CPPD
Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
What Adult Rheumatologists Need to Know about Juvenile Arthritis
How to recognize distinctions between pediatric and adult arthritis
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- Next Page »